Prognostic Value of Pharmacological Stress Echocardiography in Diabetic and Nondiabetic Patients With Known or Suspected Coronary Artery Disease
Lauro Cortigiani, MD*,*,
Riccardo Bigi, MD ,
Rosa Sicari, MD ,
Patrizia Landi, BSc ,
Francesco Bovenzi, MD* and
Eugenio Picano, MD
* Division of Cardiology, Lucca Hospital, Lucca, Italy
Cardiology, Department of Medicine and Surgery, University School of Medicine, Milan, Italy
Institute of Clinical Physiology, CNR, Pisa, Italy

View larger version (13K):
[in a new window]
|
Figure 1 Survival curves for diabetic and nondiabetic patients describing the group with ischemia, scar, and normal test.
|
|

View larger version (14K):
[in a new window]
|
Figure 2 Hard event-free survival curves for diabetic and nondiabetic patients describing the group with ischemia, scar, and normal test.
|
|

View larger version (27K):
[in a new window]
|
Figure 3 Hard event-free survival curves for diabetic and nondiabetic patients ages <65 years and 65 years, describing the group with ischemia, scar, and normal test.
|
|
|